Enhabit, Inc. (NASDAQ: EHAB), a prominent player in the healthcare sector specializing in home health and hospice services, has been drawing the attention of investors amid its recent stock movements..
Celcuity Inc. (NASDAQ: CELC), a clinical-stage biotechnology company, is gaining significant attention in the healthcare sector due to its innovative approach to cancer treatment. With a market cap of $475.6..
Capricor Therapeutics, Inc. (NASDAQ: CAPR), a clinical-stage biotechnology company, is gaining attention in the healthcare sector with its innovative approach to treating diseases with high unmet medical needs. With a..
Personalis, Inc. (NASDAQ: PSNL) is making waves in the healthcare sector, particularly within the diagnostics and research industry. With a market capitalization of $513.17 million, this U.S.-based company is carving..
REGENXBIO Inc. (NASDAQ: RGNX), a clinical-stage biotechnology company, has piqued investor interest with its promising pipeline and remarkable potential upside. With a market capitalization of $511.64 million, the company is..
Septerna, Inc. (NASDAQ: SEPN) stands out in the biotechnology sector with an intriguing investment profile, underscored by a potential upside of 127.35% according to the average analyst target price. Headquartered..
MeiraGTx Holdings plc (NASDAQ: MGTX) offers a compelling opportunity for investors seeking exposure to the burgeoning field of genetic medicine. Specializing in the development of transformative treatments for serious diseases,..
KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a dynamic player in the biotechnology sector, is capturing significant attention from investors, particularly with its potential upside of over 102%. Operating at the cutting..
COMPASS Pathways Plc (NASDAQ: CMPS), a pioneering biotechnology firm focused on mental health, is making waves in the healthcare sector. With a market capitalization of $422.9 million, this UK-based company..
Bicycle Therapeutics plc (NASDAQ: BCYC), a UK-based biotechnology firm, is capturing investor attention with a compelling potential upside of 202.33%. This clinical-stage pharmaceutical company is pioneering a new class of..
Verve Therapeutics, Inc. (NASDAQ: VERV) is capturing the attention of investors with its bold forays into the landscape of gene editing, targeting cardiovascular diseases. As a clinical-stage biotechnology company based..
SIGA Technologies Inc. (SIGA), a commercial-stage pharmaceutical company, is carving a niche within the healthcare sector, specifically targeting the health security market. Headquartered in New York, SIGA focuses on developing..
Arbutus Biopharma Corporation (NASDAQ: ABUS) stands as a noteworthy entity in the biotechnology industry, particularly for investors with a keen eye on the healthcare sector. With a current market capitalization..
AnaptysBio, Inc. (NASDAQ: ANAB), a clinical-stage biotechnology company based in San Diego, is capturing investor attention with its impressive growth potential in the healthcare sector. Specializing in delivering immunology therapeutics,..
Semler Scientific, Inc. (NASDAQ: SMLR), a pivotal player in the healthcare sector, operates within the medical devices industry, providing innovative technology solutions designed to enhance clinical effectiveness. Headquartered in Santa..
Arvinas, Inc. (NASDAQ: ARVN) is making waves in the biotechnology sector with its innovative approach to drug development, primarily focusing on the degradation of disease-causing proteins through its proprietary PROTAC..
Verastem, Inc. (NASDAQ: VSTM), a recognized name in the biotechnology sector, is catching the attention of savvy investors with a jaw-dropping potential upside of 167.86%. Operating out of Needham, Massachusetts,..
Phibro Animal Health Corporation (NASDAQ: PAHC), a prominent player in the animal health and mineral nutrition industry, has drawn attention with its impressive revenue growth rate of 32.10%. As a..
Mind Medicine (MindMed) Inc. (MNMD) has emerged as a notable player in the biotechnology sector, with a focus on developing groundbreaking treatments for brain health disorders. Despite being a clinical..
Investors with an eye for healthcare innovation may find GH Research PLC (NASDAQ: GHRS) a compelling opportunity. This Ireland-based biotechnology firm, with a market capitalization of $795.82 million, is at..
